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BACKGROUND: This study was undertaken to determine the prevalence of psychiatric disorders in infertile women
and men undergoing in vitro fertilization (IVF) treatment. METHODS: Participants were 1090 consecutive women
and men, 545 couples, attending a fertility clinic in Sweden during a two-year period. The Primary Care Evaluation
of Mental Disorders (PRIME-MD), based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edn
(DSM-IV), was used as the diagnostic tool for evaluating mood and anxiety disorders. RESULTS: Overall, 862
(79.1%) subjects ﬁlled in the PRIME-MD patient questionnaire. Any psychiatric diagnosis was present in 30.8% of
females and in 10.2% of males in the study sample. Any mood disorder was present in 26.2% of females and 9.2%
of males. Major depression was the most common mood disorder, prevalent in 10.9% of females and 5.1% of
males. Any anxiety disorder was encountered in 14.8% of females and 4.9% males. Only 21% of the subjects with
a psychiatric disorder according to DSM-IV received some form of treatment. CONCLUSIONS: Mood disorders
are common in both women and men undergoing IVF treatment. The majority of subjects with a psychiatric disorder
were undiagnosed and untreated.
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Introduction
Infertility is a stressful life event and depressive symptoms are
normal responses to the life crisis of the infertile couple. Grief
reactions are common among infertile females and males, and
the mourning process is considered important in order to
resolve the infertility crisis (Williams and Zappert, 2006).
However, in certain women and men these normal grief reac-
tions are sustained and turn into pathological grief, which is
largely consistent with the DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, 4th edn) deﬁnition of major
depression (Williams and Zappert, 2006).
Among infertile women 37% had depressive symptoms on
the Beck Depression Inventory (BDI), which was twice as
common as in the control group (Domar et al., 1992). At
onset of IVF it has been estimated that 19.4% of infertile
women had moderate to severe depressive symptoms,
whereas 54% were mildly depressed according to the Zung
Depression Scale (Demyttenaere et al., 1998). Prior to IVF,
11.6% of females reported depressive symptoms according to
BDI, while the frequency was increased to 25.4% following
failed IVF (Newton et al., 1990). According to the General
Health Questionnaire, depressive symptoms were found in 33
and 43% of females prior to IVF and following IVF, respect-
ively (Lok et al., 2002). Furthermore, anxiety symptoms in
infertile women were encountered in 10.6% of women prior
to IVF and in 14.2% of women after IVF using the State-Trait
Anxiety Inventory (STAI) (Newton et al., 1990). Most studies
report on depressive and anxiety symptoms among females,
whereas few studies report on these symptoms among men
undergoing IVF. The prevalence of depressive symptoms in
infertile men according to the BDI varied between 3.5%
prior to IVF and 8% after failed IVF (Newton et al., 1990).
No elevated scores for anxiety symptoms using the STAI
were reported among males in an assessment prior to IVF treat-
ment (Slade et al., 1997).
The variability in assessments of depressive and anxiety
symptoms in previous reports is largely determined by differ-
ences in the time points of the assessments (before, during
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Advance Access publication on June 25, 2008and/or after IVF), and methodological issues such as the use of
different standardized psychometric self-report instruments
and the use of different threshold scores (Williams et al.,
2007). One limitation of the use of self-report screening
scales is that they can merely suggest the likelihood of a psy-
chiatric disorder, whereas the use of diagnostic interviews
can reveal a psychiatric diagnosis (Spitzer et al., 1994). Conse-
quently, the prevalence of clinical psychiatric disorders, based
on DSM-IV criteria, is largely unknown among unselected
infertile couples. One previous study of Chinese women under-
going assisted reproductive treatment (ART) indicated that the
prevalences ofmajor depressionand ofgeneralized anxiety dis-
order (GAD) were 17 and 23.2%, respectively (Chen et al.,
2004). A small study compared the prevalence of psychiatric
disorders in infertile subjects speciﬁcally referred or not
referred to psychosomatic care, and found prevalence rates of
anxiety and/or depressive disorders in the latter group to be
30% in women and 16.6% in men (Guerra et al., 1998).
Major depression in the general population is two to three
times as common in women as in men (Kessler, 2003). The
12-month prevalence of major depression in a Scandinavian
population varies between 4.5–9.7% in women and 3–4.1%
in men, whereas GAD is prevalent in 1.7–4.3% of women
and 0.6–2% of men (Kringlen et al., 2001, 2006). The
12-month prevalence in the US population of any mood dis-
order is 14.1% in females and 8.5% in males, whereas any
anxiety disorder is found among 22.6% of females and
11.8% of men (Kessler et al., 1994). Furthermore, there is a
substantial comorbidity between anxiety and depression in
both females and males (Kessler et al., 1994, 2005; Breslau
et al., 1995). Depressive disorders are also associated with
increased reporting of physical symptoms such as headache,
fatigue, back pain and bowel complaints (Simon et al., 1999).
Given the lack of information concerning the prevalence of
depressive disorders and anxiety disorders in infertile couples,
this prospective study was undertaken in order to determine the
prevalence of psychiatric disorders in infertile women and men
undergoing in vitro fertilization (IVF).
Materials and Methods
Study population
From April 11, 2005, until April 13, 2007, all female and male part-
ners in consecutive couples undergoing IVF or intracytoplasmic
sperm injection (ICSI) treatment at the Centre of Reproduction,
Uppsala University Hospital, Uppsala, Sweden, were approached con-
cerning participation in the study. In Sweden, a total of 16 clinics were
offering ART during the study period. Eight of these clinics are public
and the others are private. The Centre of Reproduction at Uppsala Uni-
versity Hospital is public, and infertile couples are offered three IVF
treatments free of charge. The waiting period for ART is approxi-
mately three months. Couples can seek medical care with or without
referral. Couples who are referred for IVF treatment from areas
outside Uppsala County are pretreated at the referring clinic. Pretreat-
ment includes follicular stimulation with daily injections of gonado-
trophins (in most cases recombinant FSH), either following
down-regulation with a gonadotropin-releasing hormone (GnRH) ana-
logue or in combination with a GnRH antagonist, until follicular matu-
ration has been obtained, as monitored by regular examinations with
transvaginal ultrasonography. Oocyte retrieval was performed 34–
36 h after an injection of 10 000 IU of hCG. Subjects pretreated at
their home clinic visit the Centre of Reproduction for the ﬁrst time
on the day of oocyte retrieval. The upper age limit for IVF at the
Centre of Reproduction is 40 years for females and 55 years for males.
Study exclusion criteria were (i) inability to read and understand the
questionnaire because of language difﬁculties and (ii) couples under-
going cycles with gamete donation, i.e. oocyte and sperm donation.
Furthermore, subjects already evaluated at the time of an earlier IVF
treatment during the study period were not approached to participate.
Demographic data were collected by asking the subjects to ﬁll in a
separate questionnaire with questions on socioeconomic factors. The
fertility history was collected from the subjects’ medical reports
after all subjects had participated in the study.
Psychiatric assessment
Diagnoses of psychiatric status were assessed using the PRIME-MD
(Primary Care Evaluation of Mental Disorders) system, which was
developed to screen, evaluate and diagnose mental disorders. Given
its utility and ease of use, the PRIME-MD system was considered to
be a suitable tool for assessing the prevalence of psychiatric disorders
in this infertility setting. The PRIME-MD system was constructed to
conform to DSM-IV criteria and has been validated for use in the
primary care setting. Prior studies have indicated good agreement
between PRIME-MD diagnoses and those of independent mental
health professionals, with a sensitivity of 83%, a speciﬁcity of 88%,
a positive predictive value of 80% and an overall accuracy of 86%
(Spitzer et al., 1994). Furthermore, a self-administered version of
PRIME-MD, the PRIME-MD Patient Health Questionnaire, has
been validated for use in obstetric-gynaecologic patients (Spitzer
et al., 2000). The original PRIME-MD system, which is fully
described elsewhere (Spitzer et al., 1994), consists of two com-
ponents: a one-page patient questionnaire (PQ)and a 12-page clinician
evaluation guide (CEG), which is a structured interview guide to be
followed when evaluating the responses on the PQ. The CEG contains
modules for mood, anxiety, eating disorders, alcohol abuse, social
phobia and obsessive-compulsive disorder. Only those modules that
are indicated by the patient on the PQ are evaluated. A modiﬁed
form of the PRIME-MD PQ, containing 24 questions relating to
somatoform disorder, mood disorders, anxiety disorders and
eating disorders, was used for this study. The PRIME-MD system
evaluates the presence of 20 possible psychiatric disorders, of
which 11 were considered in this study. Eight of these 11 corre-
spond to the speciﬁc requirements of full DSM-IV diagnoses,
where evaluation and treatment are recommended, such as: major
depressive disorder, dysthymia, partial remission of major depress-
ive disorder, GAD, panic disorder, obsessive-compulsive disorder,
social phobia and bulimia nervosa. Three additional diagnoses are
considered to be “subthreshold” diagnoses: minor depressive dis-
order, anxiety not otherwise speciﬁed (NOS) and eating disorder
NOS. Subthreshold diagnoses have fewer symptoms than required
for a speciﬁc DSM-IV diagnosis but are included in the study as
they are also associated with considerable disability, as in the
case of minor depressive disorders (Beekman et al., 1997).
Bipolar disorder, alcohol abuse, somatoform disorders and
rule-out diagnoses of mood and/or anxiety due to physical disorder,
medication or drugs were not assessed.
Study design
On the day of oocyte retrieval, each eligible subject was asked for
consent to participate in the study and to complete and return the
PRIME-MD PQ. Along with the PQ they were asked to provide their
name, date of birth, telephone number and a signed informed consent
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be screen-positive if a response to any key question indicated a psy-
chiatric disorder. Screen-negative subjects were those whose
responses on the PQ did not include items suggesting psychiatric
symptoms. To conﬁrm a diagnosis in screen-positive men and
women, a telephone interview using a computerized version of the
clinical evaluation guide was conducted. As most subjects provided
their cell phone numbers, the female and male partners were inter-
viewed separately, on different occasions. In only a few cases were
both partners interviewed on the same occasion. In those cases part-
ners were interviewed one after the other, starting with the one who
answered the telephone. The telephone interview was conducted 21
days after screening, i.e. after the pregnancy test had been performed.
At the time of the telephone interview, the interviewer had no knowl-
edge of the subject or the subject’s medical records (including fertility
history and treatment outcome). In case of a PRIME-MD diagnosis,
the subject was asked about current antidepressant drug therapy
and/or psychotherapy (including therapy provided by sources
outside the Centre of Reproduction), and any previous history of
depression. All subjects with conﬁrmed full DSM-IV diagnosis
were offered referral to psychiatric specialist care. The telephone
interviews were performed by two of the authors, both of whom
had extensive clinical experience in counselling infertile couples
and research experience in assessing psychological symptoms in
IVF couples. The study was approved by the Ethics Committee,
Uppsala University, Uppsala, Sweden.
Statistical analyses
Continuous variables were compared by the use of independent t-tests
and are presented as mean+SD. Frequencies were compared
between groups using the chi-square test. All statistical analyses
were performed with SPSS 14.0. A P-value ,0.05 was considered
signiﬁcant. Demographic and fertility data were compared between
subjects with a psychiatric disorder and subjects with no psychiatric
disorder; the latter group consisted of screen-negative subjects and
screen-positive subjects in whom no psychiatric diagnosis was estab-
lished during the telephone interview.
Results
Study population
A total of 1102 patients were eligible for the study. Twelve
patients were excluded because of language difﬁculties
(inability to read/speak Swedish). Hence, a total of 1090
eligible women and men, 545 couples, were approached for
participation in the study (Fig. 1). Of these, 85 females and
93 males (16.3%) did not return their questionnaires, and
50 subjects [21 females and 29 males (4.6%)] answered their
questionnaires but were excluded as they did not consent to a
follow-up telephone interview. Overall, 862 (79.1%) subjects
ﬁlled out the PQ and consented to a telephone interview, and
the response rates were 439 (80.5%) and 423 (77.6%) among
women and men, respectively.
Among subjects who ﬁlled out the PQ, 152 (34.6%) women
and 258 (61.0%) men were screen-negative in that they did not
trigger any of the key questions for psychiatric disorders.
Overall, 452 (52.4%) women and men responded positively
to one or more of the key questions for mental disorders and
also consented to the follow-up telephone interview. Of
these, 26 (5.9%) women and 11 (2.6%) men were screen-
positive but could not be reached by telephone within the stipu-
lated 21-day period. Hence, a telephone interview was
conducted in 415 cases, and the study sample wherein a poss-
ible conﬁrmation of a psychiatric diagnosis could be made con-
sisted of 825 subjects (413 females and 412 males) (Fig. 1).
Pretreatment at referring clinics outside Uppsala county was
done in 40.9% (n ¼ 169 couples) of the study population.
Demographic and fertility data are given in Table I for female
and male subjects who agreed to participate and subjects who
did not agree to participate in the study. ICSI treatment and
previous IVF/ICSI treatment were more prevalent in men who
declined to participate in the study than in men who participated
in the study, P , 0.05. Demographic and fertility data are given
in Table II for female and male subjects with or without
Figure 1: The study population consisted of screen negative, screen positive and diagnosed subjects, n ¼ 825 (413 females and 412 males).
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jects who received a psychiatric diagnosis and the group with
no psychiatric diagnosis when analyses were done separately
in men and women. However, when both sexes were combined,
smoking and unemployment were more common among sub-
jects with a psychiatric diagnosis, P , 0.05.
Prevalence of psychiatric disorders
Of the 413 women in the study sample, 127 (30.8%) had one or
more psychiatric diagnoses. The corresponding ﬁgure for the
412 males was 42 (10.2%). The difference between females
and males was signiﬁcant (P , 0.001). Prevalence rates of psy-
chiatric disorders detected by PRIME-MD in the total sample
Table II. Demographic and fertility data for infertile women and men with or without psychiatric diagnosis.
Female subjects, n ¼ 413 Male subjects, n ¼ 412
Psychiatric diagnosis,
n ¼ 127
No psychiatric diagnosis,
n ¼ 286
Psychiatric diagnosis,
n ¼ 42
No psychiatric diagnosis,
n ¼ 370
Age, years 32.7+4.1 32.9+3.7 35.5+4.5 34.6+4.8
BMI, kg/m
2 24.7+4.1 23.9+4.1 26.1+4.4 25.5+3.3
Smokers, n (%) 10 (7.9) 13 (4.5) 4 (9.5) 15 (4.1)
Snuff taking status, n (%) 3 (2.4) 11 (3.8) 10 (23.8) 101 (27.4)
University/College, n (%) 64 (50.4) 156 (54.5) 17 (40.5) 165 (44.6)
High school education, n (%) 63 (49.6) 130 (45.5) 25 (59.5) 205 (55.4)
Employee/student
a, n (%)
b 75 (59.1) 165 (57.7) 19 (45.2) 222 (60.0)
Unemployed
a, n (%)
b 8 (6.3) 8 (2.8) 3 (7.1) 10 (2.7)
Duration, months 38.3+20.2 38.8+19.2 39.7+20.6 38.0+19.4
Infertility factors, n (%)
Female 41 (32.3) 81 (28.3) 8 (19.0) 115 (31.1)
Male 42 (33.0) 86 (30.1) 14 (33.3) 111 (30.0)
Unexplained 41 (32.3) 105 (36.7) 17 (40.5) 128 (34.6)
Other
b 3 (2.4) 14 (4.9) 3 (7.1) 16 (4.3)
Previous pregnancy, n (%)
No 81 (63.8) 208 (72.7)
Yes 46 (36.2) 78 (27.3)
Parity, n (%)
Nullipara 113 (89.0) 261 (91.3)
Multipara 14 (11.0) 25 (8.7)
IVF 78 (61.4) 175 (61.2) 23 (54.8) 253 (63.0)
ICSI 49 (38.6) 111 (38.8) 19 (45.2) 137 (37.0)
Previous IVF/ICSI, n (%)
No 92 (72.4) 215 (75.2) 27 (64.3) 285 (77.0)
Yes 35 (27.6) 71 (24.8) 15 (35.7) 85 (33.0)
No signiﬁcant differences were found between the groups.
amissing data; a total of 157 (38.0%) females and 158 (38.3%) males (This question was included
later in the study);
bother causes or not evaluated. BMI, body mass index.
Table I. Demographic and fertility data for included women and men versus women and men not included in the study.
Females, n ¼ 545 Males, n ¼ 545
Study group, n ¼ 413 Not included
a, n ¼ 132 Study group, n ¼ 412 Not included
a, n ¼ 133
Age (years) 32.9+3.9 32.2+4.9 34.7+4.8 35.3+3.5
BMI (kg/m
2) 24.2+3.9 24.3+4.3 25.5+3.4 26.5+2.8
Duration (months) 38.6+19.5 40.5+23.6 38.2+19.5 44.4+21.0
Infertility factors, n (%)
Female 122 (29.5) 31 (23.5) 123 (29.8) 30 (22.6)
Male 128 (31.0) 48 (36.4) 125 (30.3) 51 (38.3)
Unexplained 146 (35.4) 37 (28.0) 145 (35.2) 38 (28.6)
Other
b 17 (4.1) 10 (7.6) 19 (4.7) 8 (6.0)
Previous pregnancy, n (%)
No 289 (70.0) 94 (74.6)
Yes 124 (30.0) 32 (25.4)
Parity, n (%)
Nullipara 374 (90.6) 118 (90.1)
Multipara 39 (9.4) 13 (9.9)
IVF 253 (61.3) 68 (51.5) 256 (62.1) 65 (48.9)
ICSI 160 (38.7) 58 (44.0) 156 (37.9) 62 (46.6)*
Previous IVF/ICSI, n (%)
No 308 (74.6) 91 (68.9) 312 (75.7) 86 (64.7)
Yes 105 (25.4) 41 (31.1) 100 (24.3) 47 (35.3)*
aMissing data; not included n ¼ 6 (4.5%);
bother causes or not evaluated. *Signiﬁcantly different from included males, P , 0.05. BMI, body mass index.
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(4.4%), both the female and the male within the couple had
any psychiatric diagnosis. Comorbidity was common among
the 127 females with a psychiatric diagnosis; 46 (36.2%)
females had two diagnoses, and 10 (7.9%) females had three
or more diagnoses. Of the 42 males with a psychiatric diagno-
sis, 16 (38.1%) had two diagnoses, and ﬁve (11.9%) had three
or more diagnoses.
Full DSM-IV diagnoses (i.e. diagnoses with speciﬁc
requirements in the DSM-IV, subthreshold diagnoses not
included) were present in 111 subjects, 81 (19.6%) women
and 30 men (7.3%), while 46 (11.1%) women and 12
(2.9%) men had a subthreshold diagnosis. Among subjects
with a full DSM-IV diagnosis only 23 subjects (20.7%)
were receiving some form of treatment for their psychiatric
condition. Twenty (18%) subjects received some form of psy-
chotherapy, and seven (6.3%) subjects had been prescribed
antidepressant treatment with or without psychotherapy. In
the study sample, i.e. not only among those who received a
psychiatric diagnosis, a total of 89 (10.8%) subjects received
counselling during investigation and/or IVF treatment. A
total of 78 (46.2%) women and men with psychiatric dis-
orders reported a previous history of depression. Of the sub-
jects with full DSM-IV diagnoses, 49 (60.5%) of the females
and 16 (53.3%) of the males reported a previous history of
depression. Recurrent thoughts of death were reported by 8
(10.5%) females and 5 (16.7%) males diagnosed with a
major depression and of these, 7 females and 3 males were
undergoing their ﬁrst IVF.
Physical symptoms were more common among females and
males with a psychiatric diagnosis than in the group without a
diagnosis. The frequencies of reported physical symptoms are
presented in Table IV. The most common symptoms among
females with a psychiatric diagnosis were fatigue, headache,
nausea and abdominal pain, whereas fatigue and insomnia
were the physical symptoms most commonly reported by
men with a psychiatric diagnosis.
Discussion
To our knowledge, this is the ﬁrst study to describe the preva-
lence of psychiatric disorders in both women and men under-
going IVF treatment. Approximately 30% of the infertile
women and 10% of the infertile men in the present study
fulﬁlled criteria for a depressive and/or anxiety disorder,
including subthreshold diagnoses. Depressive disorders were
more common than in the general population, whereas preva-
lence rates of anxiety disorder were similar (Kessler et al.,
1994; Kringlen et al., 2001, 2006). Major depression was the
most prevalent psychiatric disorder in both women and men.
The majority of subjects with a psychiatric disorder were
undiagnosed and untreated for that disorder, which is also in
accordance with what is found in the general population
(Kessler et al., 1994; Le ´pine et al., 1997).
One explanation as to why depression is not always recog-
nized in the infertility setting could be that infertile couples
are reluctant to report depressive symptoms to the IVF team.
The couples are eager to appear well adjusted, presumably
because they fear that IVF treatment will be denied or post-
poned if psychiatric problems are revealed (Demyttenaere
et al., 1998; Williams and Zappert, 2006). Furthermore, the
couples tend to have unrealistically high expectations of a suc-
cessful outcome after the ﬁrst treatment (Slade et al., 1997;
Hammarberg et al., 2001), and their positive attitudes before
the start of the ﬁrst treatment may disguise an ongoing
depression.
A major ﬁnding of this study was that only a small pro-
portion of those identiﬁed with a psychiatric disorder received
ongoing treatment. The ﬁrst choice for treatment of depression
in infertile females is psychotherapy rather than pharmacother-
apy to avoid both interference with the woman’s attempt to
conceive and medication interactions (Williams and Zappert,
2006). Cognitive Behavioural Therapy (CBT) has been
shown to reduce mental stress in females undergoing IVF
(Facchinetti et al. 2004) and has also been demonstrated to
be an efﬁcient treatment for depression in other populations
Table III. Prevalence of psychiatric disorders detected by PRIME-MD.
Psychiatric disorder Females, n ¼ 413 (%) Males, n ¼ 412 (%)
Any psychiatric diagnosis 127 (30.8) 42 (10.2)
Threshold diagnoses (full DSM-IV diagnoses)
a 81 (19.6) 30 (7.3)
Subthreshold diagnoses
b 46 (11.1) 12 (2.9)
Any mood disorder
c 108 (26.2) 38 (9.2)
Major depressive disorder 45 (10.9) 21 (5.1)
Dysthymia 6 (1.4) 1 (0.2)
Partial remission of major depressive disorder 25 (6.1) 8 (1.9)
Minor depressive disorder 35 (8.5) 9 (2.2)
Any anxiety disorder
c 61 (14.8) 20 (4.9)
Anxiety NOS 46 (11.1) 16 (3.9)
Generalized anxiety disorder 7 (1.7) 3 (0.7)
Panic disorder 5 (1.2) 2 (0.5)
Obsessive-compulsive disorder 8 (1.9) 1 (0.2)
Social phobia 5 (1.2) 2 (0.4)
Eating disorder NOS 1 (0.2) 0
aFull DSM-IV diagnoses; major depressive disorder, dysthymia, partial remission of major depressive disorder, generalized anxiety disorder, panic disorder,
obsessive-compulsive disorder, social phobia and bulimia nervosa;
bsubthreshold diagnoses; minor depressive disorder, anxiety NOS and eating disorder NOS;
csubjects can have one or more psychiatric diagnoses within any mood and/or any anxiety disorders.
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siderably between clinics and this may explain why treatment
may not be accessible to all patients. Psychotherapy in the
form of counselling was received by one-ﬁfth of the subjects
with a psychiatric diagnosis and by one in ten of all subjects
in this study. This is surprisingly few, as all couples are
informed about and offered counselling at their initial visit to
the clinic. However, similar low rates of counselling have pre-
viously been reported by Boivin et al. (1999), who found that
only 11% of females and males received counselling while
attending an infertility clinic. Thus, an important task for the
IVF team would be not only to identify females and males
with depression, but also to assure that adequate treatment is
initiated. Furthermore, as waiting times for IVF are being
reduced, it is important to offer treatment not only before the
ﬁrst IVF treatment, but also in between treatments.
Somewhat surprisingly, fertility factors such as age of the
female, duration of infertility, infertility diagnosis and
numbers of previous IVF/ICSI treatments were not associated
with psychiatric disorders in this study population. Other
factors such as personality traits and coping strategies are pre-
sumably more important predictors of psychiatric morbidity
than fertility history. This assumption is also corroborated by
ﬁndings in burn survivors, where personality and coping strat-
egies have been shown to more reliably predict psychological
outcome than the severity of the burn injury (Kildal et al.,
2004; Willebrand et al., 2004).
On the other hand, fertility factors appear to have inﬂuenced
readiness to participate in the study. Men who declined to
participate more often had male factor infertility than men
who participated. As men with male factor infertility have
been shown to be more mentally distressed than men in
couples with other causes of infertility (Laffont and Edelmann,
1994), it is plausible that the prevalence of psychiatric
disorders among male participants in this study has been
underestimated.
The prevalence rates of depression and anxiety disorders in
the current study may be the result of difﬁculties involved
in dealing with infertility and undergoing IVF treatment.
However, it must be emphasized that the prevalence rates of
depression and/or anxiety disorders among infertile females
in the present study are similar to those found in unselected
gynaecological outpatients, where 30.5% suffered from
any psychiatric disorder and 10% had a major depression
(Sundstrom et al., 2001). Hence, depression and/or anxiety
disorders do not appear to be more common in infertile
females compared with patients in gynaecologic practice.
However the prevalence rates of depression and/or anxiety
disorder are higher in infertile females when compared with
a population-based study of pregnant women in the second
trimester. The prevalence of any depressive disorder in preg-
nant women was 11.6%, and the prevalence of any anxiety dis-
order was 6.6% (Andersson et al., 2003).
Comorbidity was often encountered in the present study,
where one-third of both females and males with psychiatric dis-
orders had two or more diagnoses. These results are in agree-
ment with previous studies suggesting that depression and
anxiety often co-exist (Breslau et al., 1995). Likewise, in
analogy with prior ﬁndings, physical symptoms were signiﬁ-
cantly more frequent among females and males with a psychia-
tric diagnosis than in subjects without a diagnosis (Kroenke and
Spitzer, 1998; Sundstrom et al., 2001; Andersson et al., 2003).
There are several limitations to the present study. First, psy-
chiatric diagnoses were based on the use of a screening ques-
tionnaire followed by a structured psychiatric interview
conducted by telephone. The PRIME-MD interview was pri-
marily designed to be used by primary care physicians, but
the use of telephone interviews in this situation is less well
studied. However, telephone interviews are commonly used
in large-scale population-based studies of psychiatric disorders
because of their demonstrated comparability with face-to-face
research interviews (Wells et al., 1988; Spitzer et al., 1994;
Evans et al., 2004). For this reason, and because almost half
of the subjects were living outside of Uppsala, telephone inter-
views were used for the psychiatric assessments in the present
study.
Table IV. Frequency of physical symptoms by prevalence of any PRIME-MD diagnosis.
Female subjects, n ¼ 413 (%) Male subjects, n ¼ 412
Psychiatric diagnosis, n ¼ 127 No psychiatric diagnosis, n ¼ 286 Psychiatric diagnosis, n ¼ 42 No psychiatric diagnosis, n ¼ 370
Fatigue 111 (87.4)*** 171 (59.6) 31 (73.8)*** 91 (25.0)
Headache 83 (65.4) ** 134 (46.9) 17 (40.5)** 60 (16.3)
Nausea 71 (55.9)*** 100 (34.8) 13 (31.0)** 39 (10.7)
Abdominal pain 69 (55.6)*** 96 (33.6) 8 (19.0)** 21 (5.7)
Bowel complaints 60 (48.0)*** 84 (29.3) 12 (28.6)** 37 (10.2)
Insomnia 55 (44.0)*** 58 (20.2) 23 (54.8)*** 53 (14.6)
Dysmenorrhea 50 (40.0)* 88 (30.9)
Dizziness 43 (33.9)*** 49 (17.1) 9 (21.4)*** 10 (2.7)
Back pain 38 (29.9)* 56 (19.5) 11 (26.2)* 50 (13.6)
Joint or limb pain 27 (21.8)* 38 (13.3) 10 (23.8) ns 50 (13.7)
Palpitations 21 (16.8)* 27 (9.4) 1 (2.4) ns 7 (1.9)
Chest pain 21 (16.5)** 17 (5.9) 6 (14.3)** 10 (2.7)
Sexual problems 19 (15.1)* 23 (8.1) 0 5 (1.4)
Dyspnea 7 (5.6)* 5 (1.7) 5 (12.2)** 4 (1.1)
Fainting 4 (3.1)* 2 (0.7) 2 (4.8)* 1 (0.3)
Not all subjects answered all questions. *P , 0.05 compared with respective control group, chi-square test; **P , 0.01 compared with respective control group,
chi-square test; ***P , 0.001 compared with respective control group, chi-square test. ns, not signiﬁcant.
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time points for assessment of psychiatric disorders, with
initial screening on the day of oocyte retrieval and telephone
interviews after the IVF treatment. As the subjects completed
the ﬁrst assessment (screening) on the day of oocyte retrieval,
it may have been difﬁcult to clearly distinguish previous
anxiety from anxiety caused by anticipation of oocyte retrieval
procedures and concerns about the outcome of the treatment.
However, these time points were chosen because it has pre-
viously been shown that anxiety symptoms peak on the day
of oocyte retrieval (Boivin et al., 1998), and by screening sub-
jects on this day we increased the sensitivity of the method.
Also, by conducting the second assessment three weeks later,
after the pregnancy test, it can be assumed that
treatment-related transient changes in depressive and anxiety
symptoms have declined, thus reducing the risk of false-
positive psychiatric diagnoses. Another reason for our choice
of time points for the assessments was that almost half of the
women were pretreated at referring clinics and did not visit
our clinic until the day of oocyte retrieval. If psychiatric assess-
ments had been carried out earlier during the course of IVF
treatment, we would have been able to recruit only a very
limited population. Undergoing IVF treatment can be extre-
mely stressful for the couple, and psychiatric assessments,
whether performed before, during or after treatment, will
result in various types of biases that might inﬂuence the results.
Other limitations of the study were that substance-related
disorders were not assessed and that women and men with
language difﬁculties were excluded. It can be assumed that sub-
jects with foreign backgrounds more often suffer from
depression, as heightened depression scores have been reported
previously in this group (Beutel et al., 1999).
The limitations of the current study also indicate the need
for additional studies of the prevalence of psychiatric dis-
orders in subjects undergoing IVF treatment. For example,
in this study three out of four couples were undergoing
their ﬁrst IVF and fewer than one in ten was undergoing
their third IVF. It is unclear whether prevalence of psychia-
tric disorders after the third and for most couples the last IVF
is different from subjects who undergo their ﬁrst IVF.
Furthermore, most couples are lost to follow-up after the
last IVF, and even less is known about the psychological
health of subjects who never conceive following IVF (Ham-
marberg et al., 2001).
In conclusion, this study suggests that mood disorders, and in
particular major depression, are common in infertile women
and men undergoing IVF treatment. The majority of subjects
with a psychiatric disorder were undiagnosed and untreated.
It is an important task for the IVF team not only to identify
females and males with depression, but also to assure that
adequate treatment is initiated.
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